EVALUATION OF THE TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORALLY ADMINISTERED DWP05195, A NEW TRPV1 ANTAGONIST IN HEALTHY ADULT MALE VOLUNTEERS.

被引：0
|
作者：
Lee, S. [1 ]
Jiang, F. [1 ]
Lee, J. [1 ]
Chung, J. [2 ,3 ]
Jang, I. [1 ]
Lee, H. [1 ]
Yu, K. [1 ]
Jang, K. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Songnam, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-060
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 46 条
  • [1] PHARMACOKINETCS, PHARMACODYNAMICS AND TOLERABILITY OF DWP05195, A NOVEL TRPV1 ANTAGONIST, AFTER MULTIPLE ORAL DOSES IN HEALTHY VOLUNTEERS
    Lee, J.
    Lee, S.
    Gu, N.
    Kim, B.
    Choi, Y.
    Kim, J.
    Kim, H.
    Park, S.
    Lee, H.
    Yu, K.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S26 - S26
  • [2] PHARMACOKINETICS AND TOLERABILITY OF A NEW TRPV1 ANTAGONIST AFTER MULTIPLE ADMINISTRATIONS IN HEALTHY VOLUNTEERS.
    Cha, Y. J.
    Gu, N.
    Shin, D.
    Lim, K. S.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S71 - S72
  • [3] A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
    Lee, Jieon
    Kim, Bo-Hyung
    Yu, Kyung-Sang
    Kim, Hee Sun
    Kim, Ji Duck
    Cho, Joo-Youn
    Lee, SeungHwan
    Gu, Namyi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1301 - 1313
  • [4] Relative bioavailability, pharmacokinetics and pharmacodynamics of a new clopidogrel formulation in healthy male volunteers.
    Kim, S.
    Lee, H.
    Kwan, E.
    Kim, E.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S59 - S59
  • [5] Safety, tolerability, pharmacodynamics and pharmacokinetics of teverelix following single or repeated doses administered subcutaneously to healthy female volunteers.
    Maclean, CM
    Larsen, F
    Beglinger, C
    Piechatzek, R
    Drewe, J
    FERTILITY AND STERILITY, 2005, 84 : S352 - S353
  • [6] Effect of ranitidine on the pharmacokinetics of orally administered eprosartan, an angiotensin II antagonist, in healthy male volunteers
    Tenero, DM
    Martin, DE
    Ilson, BE
    Boyle, DA
    Boike, SC
    Carr, AM
    Lundberg, DE
    Jorkasky, DK
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 304 - 308
  • [7] SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE RISING ORAL DOSES OF BI 1021958, A NOVEL CRTH2 ANTAGONIST, IN HEALTHY MALE VOLUNTEERS.
    Koenen, R.
    Fowler, A.
    Gupta, A.
    Hilbert, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S78 - S78
  • [8] TRPV1 Antagonist DWP05195 Induces ER Stress-Dependent Apoptosis through the ROS-p38-CHOP Pathway in Human Ovarian Cancer Cells
    Wang, Yi-Yue
    Lee, Kyung-Tae
    Lim, Myong Cheol
    Choi, Jung-Hye
    CANCERS, 2020, 12 (06) : 1 - 14
  • [9] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE DOSES OF THE TRPV1 ANTAGONIST SAF312 IN HEALTHY SUBJECTS
    El Mouelhi, M.
    Bartlett, M.
    Roberts, J.
    Vaidya, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S68 - S68
  • [10] Pharmacokinetics (PK) and pharmacodynamics (PD) of orally (PO) administered midazolam (MDZ) in the presence and absence of intravenous (IV) flumazenil (F) in healthy volunteers.
    Lawendy, NM
    Holt, JL
    Fullerton, T
    Nafziger, AN
    Snyder, PJ
    Victory, J
    Bertino, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P15 - P15
12345